NCT00758693View on ClinicalTrials.gov

Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia (CLL)

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG

Bendamustine

Bendamustine 100 mg/m2 intravenously on days 1 and 2 on a 28-day cycle for 6 cycles

DRUG

Rituximab

Rituximab 500 mg/m2 on a 28-day cycle for 6 cycles

Trial Locations (1)

40536

University of Kentucky, Lexington

Sponsors

Collaborators (1)

Cephalon
All Listed Sponsors
collaborator

Cephalon

INDUSTRY

lead

University of Kentucky

OTHER